169 related articles for article (PubMed ID: 29479339)
1. The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes.
Lebenthal Y; Levy S; Sofrin-Drucker E; Nagelberg N; Weintrob N; Shalitin S; de Vries L; Tenenbaum A; Phillip M; Lazar L
Front Endocrinol (Lausanne); 2018; 9():27. PubMed ID: 29479339
[TBL] [Abstract][Full Text] [Related]
2. New insights into clinical features, karyotypes, and age at diagnosis in women with Turner syndrome.
Frelich J; Irzyniec T; Lepska K; Jeż W
Endokrynol Pol; 2019; 70(4):342-349. PubMed ID: 31073987
[TBL] [Abstract][Full Text] [Related]
3. Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?
Krzyścin M; Sowińska-Przepiera E; Gruca-Stryjak K; Soszka-Przepiera E; Syrenicz I; Przepiera A; Bumbulienė Ž; Syrenicz A
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790996
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.
Mavinkurve M; O'Gorman CS
BBA Clin; 2015 Jun; 3():304-9. PubMed ID: 26673162
[TBL] [Abstract][Full Text] [Related]
5. Isochromosome Xq and the risk of metabolic comorbidities in Turner syndrome.
Malhotra R; Shukla R; Rastogi V; Khadgawat R
Diabetes Metab Syndr; 2023 Feb; 17(2):102708. PubMed ID: 36696722
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes.
Birjiniuk A; Weisman AG; Laternser C; Camarda J; Brickman WJ; Habiby R; Patel SR
Pediatr Cardiol; 2023 May; ():. PubMed ID: 37147524
[TBL] [Abstract][Full Text] [Related]
7. Monosomy for the X-chromosome is associated with an atherogenic lipid profile.
Van PL; Bakalov VK; Bondy CA
J Clin Endocrinol Metab; 2006 Aug; 91(8):2867-70. PubMed ID: 16705071
[TBL] [Abstract][Full Text] [Related]
8. Predicted health care profile after transition to adult care in Turner syndrome children-experience of single center.
Witkowska-Krawczak E; Erazmus M; Majcher A; Pyrżak B; Kucharska AM
Front Pediatr; 2023; 11():1173419. PubMed ID: 37325345
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study.
Frontini MG; Srinivasan SR; Berenson GS
Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1398-404. PubMed ID: 14574352
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
11. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome.
Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH
Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357
[TBL] [Abstract][Full Text] [Related]
12. Karyotype classification, clinical manifestations and outcome in 124 Turner syndrome patients in China.
Wu HH; Li H
Ann Endocrinol (Paris); 2019 Feb; 80(1):10-15. PubMed ID: 29580553
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome.
El-Mansoury M; Barrenäs ML; Bryman I; Hanson C; Larsson C; Wilhelmsen L; Landin-Wilhelmsen K
Clin Endocrinol (Oxf); 2007 May; 66(5):744-51. PubMed ID: 17381484
[TBL] [Abstract][Full Text] [Related]
14. Karyotype - Phenotype Associations in Patients with Turner Syndrome.
Noordman ID; van der Velden JA; Timmers HJ; Pienkowski C; Köhler B; Kempers M; Reisch N; Richter-Unruh A; Arlt W; Nordenström A; Webb EA; Roeleveld N; Claahsen-van der Grinten HL
Pediatr Endocrinol Rev; 2019 Apr; 16(4):431-440. PubMed ID: 31245938
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular abnormalities in patients with Turner syndrome according to karyotype: own experience and literature review.
Poprawski K; Michalski M; Ławniczak M; Łacka K
Pol Arch Med Wewn; 2009; 119(7-8):453-60. PubMed ID: 19776685
[TBL] [Abstract][Full Text] [Related]
16. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
Fechner PY; Davenport ML; Qualy RL; Ross JL; Gunther DF; Eugster EA; Huseman C; Zagar AJ; Quigley CA;
J Clin Endocrinol Metab; 2006 Dec; 91(12):4896-902. PubMed ID: 16968797
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure and Turner syndrome.
Nathwani NC; Unwin R; Brook CG; Hindmarsh PC
Clin Endocrinol (Oxf); 2000 Mar; 52(3):363-70. PubMed ID: 10718835
[TBL] [Abstract][Full Text] [Related]
18. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood.
Fiot E; Zénaty D; Boizeau P; Haignere J; Dos Santos S; Léger J;
Eur J Endocrinol; 2019 Jun; 180(6):397-406. PubMed ID: 30991358
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy.
Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E
Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
